EUVIMEDEUVIMED entdecken
Crossref

Association between Serum Ceruloplasmin level and Dyslipidemia: Study in Tertiary care Teaching Hospital

Dr. Vaishali Dhat, Dr Miss Madhura Tinaikar, Dr. Alka Sontakke

International Journal of Medical Research and Review · 2013

DOI: 10.17511/ijmrr.2013.i03.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Research and Review, 2013. Verfasst von Dr. Vaishali Dhat und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dyslipidemia is one of the major morbid events preceding CAD all around. The conventional risk factors have failed to predict the risk of coronary events in around 30 – 40% cases; hence an emphasis is being given to search new able risk factors. With this respect the study tried to evaluate the correlation of serum ceruloplasmin levels in dyslipidemic patients. The aim of the study was to study the correlation of serum ceruloplasmin and Dyslipidemia.

Methods

60 Subjects were screened for dyslipidemia by estimation of serum total cholesterol, triacylglycerol, HDL and LDL and were categorized into cases and controls and serum ceruloplasmin was estimated in all of them.

Results

Serum mean ceruloplasmin level in dyslipidemics was significantly raised as compared to controls. Odds ratio as high as 15.54 shows a positive correlation of serum ceruloplasmin and dyslipidemia. Ceruloplasmin levels are associated with dyslipidemia( especially LDL values) showing ‘positive r values’ and ‘p’ value is significant.

Discussion

Raised serum ceruloplasmin levels in dyslipidemics as compared to normal healthy subjects suggest that dyslipidemics are more prone for rise in ceruloplasmin levels than the healthy subjects supporting our hypothesis that raised serum ceruloplasmin levels could enhance the risk for coronary artery diseases. Raised serum Ceruloplasmin level in association with LDL values in dyslipidemics should be considered as an added risk factor for CAD. Antioxidant supplementation orally to reduce ceruloplasmin levels can be considered as a new approach of treatment in the future.

Zitieren

APA

Dhat, D. V., Tinaikar, D. M. M., & Sontakke, D. A. (2013). Association between Serum Ceruloplasmin level and Dyslipidemia: Study in Tertiary care Teaching Hospital. International Journal of Medical Research and Review. https://doi.org/10.17511/ijmrr.2013.i03.03

Vancouver

Dhat DV, Tinaikar DMM, Sontakke DA. Association between Serum Ceruloplasmin level and Dyslipidemia: Study in Tertiary care Teaching Hospital. International Journal of Medical Research and Review. 2013. doi:10.17511/ijmrr.2013.i03.03

BibTeX
@article{Dhat2013,
  author = {Dhat, Dr. Vaishali and Tinaikar, Dr Miss Madhura and Sontakke, Dr. Alka},
  title = {Association between Serum Ceruloplasmin level and Dyslipidemia: Study in Tertiary care Teaching Hospital},
  journal = {International Journal of Medical Research and Review},
  year = {2013},
  doi = {10.17511/ijmrr.2013.i03.03}
}
Kostenlos starten →